BPC-157 Side Effects There is little scientific documentation of BPC-157 side effects in humans, so most potential side effects are extrapolated from preclinical studies and anecdotal reports of human use
Others notice steady improvement over several days
doi: 10.1192/j.eurpsy.2025.10125 Summary Keywords dopamine, GABA, ghrelin, GLP-1 RA, inflammation, leptin, suicidality Citation Borovcanin MM and Petrovic I (2026) Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation
Neither BPC-157 nor TB-500 is FDA-approved, and the FDA has specifically flagged BPC-157, so these remain research-stage compounds discussed only in a wellness-support context
Their capacity for pleasure and healing is astounding
Effective in managing peripheral neuropathy, including diabetic neuropathy and other nerve-related disorders